老年肺癌患者化疗期间睡眠障碍与免疫功能的相关性及非药物干预效果研究
CSTR:
作者:
作者单位:

(空军军医大学第一附属医院西京医院呼吸与危重症医学科,西安 771032)

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(82270526);陕西省级科技计划(2022SF-274)


Correlation between sleep disorders and immune function in elderly patients with lung cancer during chemotherapy and effect of non-pharmacological intervention
Author:
Affiliation:

(Department of Respiratory and Critical Care Medicine, Xijing Hospital, the First Affiliated Hospital of Air Force Medical University, Xi′an 771032, China)

Fund Project:

This work was supported by National Natural Science Foundation of China(82270526)and Shaanxi Provincial Science and Technology Program(2022SF-274).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 分析老年肺癌患者化疗期间睡眠障碍与免疫功能的相关性,并评估非药物干预对睡眠障碍的应用效果。方法 对2022年1月至2024年12月空军军医大学第一附属医院西京医院收治的158例化疗的老年肺癌患者进行问卷调查,问卷内容包括睡眠质量[匹兹堡睡眠质量指数(PSQI)]、体能状态[Karnofsky体能状态评分(KPS)]、疲乏(癌症疲乏量表)、焦虑[广泛性焦虑量表(GAD-7)]、抑郁[9条目患者健康问卷(PHQ-9)]、疼痛[疼痛视觉模拟评分法(VAS)]。158例患者的有效回收率为95.57%(151/158),根据PSQI得分将老年肺癌患者分为睡眠障碍组(PSQI≥7分)与睡眠良好组(PSQI<7分)。比较两组患者基线资料及化疗前后免疫功能(T淋巴细胞亚群CD4+、CD8+、CD4+/CD8+),采用Pearson相关性分析老年肺癌化疗患者PSQI评分与各项指标的相关性;将睡眠障碍组采用随机数字表法分为观察组与对照组,对照组给予常规睡眠健康教育,观察组联合心理及运动干预,比较两组干预前及干预2周后睡眠质量(PSQI)和免疫功能(CD4+、CD8+、CD4+/CD8+)变化。采用SPSS 26.0软件进行数据分析。根据数据类型,组间比较分别采用t检验、χ2检验及Mann whitney U检验。结果 老年肺癌化疗患者睡眠障碍发生率为35.76%(54/151)。睡眠障碍组疲乏及GAD-7、PHQ-9、VAS评分均高于睡眠良好组(P<0.05),化疗后CD4+及CD8+、CD4+/CD8+均低于睡眠良好组(P<0.05)。Pearson相关性分析结果显示,老年肺癌化疗患者PSQI评分与疲乏评分、GAD-7评分、PHQ-9评分、VAS评分均呈显著正相关(r=0.543、0.621、0.595、0.617;P<0.05),与化疗后CD4+、化疗后CD8+、化疗后CD4+/CD8+均呈显著负相关(r=-0.584、-0.489、-0.427;P<0.05)。54例睡眠障碍组患者被随机分为观察组(n=27例)与对照组(n=27例),分别剔除1例、2例脱组病例。干预2周后,两组PSQI评分均较干预前降低(P<0.05),且观察组干预后PSQI评分低于对照组(P<0.05);两组干预前后CD4+、CD8+、CD4+/CD8+比较,差异均有统计学意义(均P>0.05)。结论 老年肺癌患者化疗期间睡眠障碍与免疫功能、疼痛、疲乏、焦虑、抑郁均有关,非药物睡眠干预对改善患者睡眠质量有利,但短期干预对免疫功能影响较小。

    Abstract:

    Objective To analyze the correlation between sleep disorders and immune function in elderly patients with lung cancer during chemotherapy and to evaluate the application effect of non-pharmacological intervention on sleep disorders. Methods A questionnaire survey was conducted among 158 elderly lung cancer patients who received chemotherapy in Xijing Hospital, the First Affiliated Hospital of Air Force Military Medical University from January 2022 to December 2024. The questionnaire included sleep quality [Pittsburgh sleep quality index (PSQI)], physical status [Karnofsky performance status (KPS)], fatigue (cancer fatigue scale), anxiety [generalized anxiety disorder-7 (GAD-7)], depression [patient health questionnaire-9 (PHQ-9)], and pain [visual analogue scale (VAS)]. The effective recovery rate was 95.57% (151/158). According to PSQI score, the patients were divided into a sleep disorder group (PSQI≥7 points) and a good sleep group (PSQI<7 points). The baseline data and immune function (T lymphocyte subsets CD4+, CD8+, CD4+/CD8+) before and after chemotherapy were compared between the two groups. Pearson correlation analysis was used to assess the correlation between PSQI scores and each indicator in elderly lung cancer patients undergoing chemotherapy. The sleep disorder group was divided into an observation group and a control group using random number table method. The control group received routine sleep health education, while the observation group was received additional psychological and exercise interventions. Changes in sleep quality (PSQI) and immune function (CD4+, CD8+, CD4+/CD8+) before intervention and after 2 weeks of intervention were compared. SPSS 26.0 was used for statistical analysis. Data comparison between two groups was performed using t test, χ2 test or Mann whitney U test depending on data type. Results The incidence rate of sleep disorders in elderly lung cancer patients undergoing chemotherapy was 35.76% (54/151). The scores of fatigue, GAD-7, PHQ-9, and VAS in the sleep disorder group were higher than those in the good sleep group (P<0.05), while CD4+, CD8+, and CD4+/CD8+ after chemotherapy were lower than those in the good sleep group (P<0.05). Pearson correlation analysis showed that PSQI scores in the elderly lung cancer patients undergoing chemotherapy was positively correlated with fatigue, GAD-7, PHQ-9, and VAS scores (r=0.543,0.621,0.595,0.617; P<0.05), and negatively correlated with post-chemotherapy CD4+, CD8+, and CD4+/CD8+ (r=-0.584, -0.489, -0.427; P<0.05). The 54 patients in the sleep disorders were randomized into an observation group (n=27) and a control group (n=27), with 1 and 2 dropouts being excluded from the respective group. After 2 weeks of intervention, PSQI scores in both groups decreased compared with that before intervention (P<0.05), and PSQI scores in observation group after intervention were lower than that in the control group (P<0.05). There were no statistical differences in CD4+, CD8+, and CD4+/CD8+ between the two groups before and after intervention (all P>0.05). Conclusion Sleep disorders in elderly lung cancer patients during chemotherapy are related to immune function, pain, fatigue, anxiety, and depression. Non-pharmacological sleep interventions are beneficial for improving patients′ sleep quality, but short-term intervention has little effect on immune function.

    参考文献
    相似文献
    引证文献
引用本文

汤玲,高苗,左秀萍.老年肺癌患者化疗期间睡眠障碍与免疫功能的相关性及非药物干预效果研究[J].中华老年多器官疾病杂志,2026,25(5):326-331
DOI:10.11915/j. issn.1671-5403.2026.05.068

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-05-24
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-05-26
  • 出版日期:
文章二维码